Literature DB >> 32363761

Low dopamine transporter binding in the nucleus accumbens in geriatric patients with severe depression.

Hiroki Moriya1, Mikael Tiger1,2, Amane Tateno1, Takeshi Sakayori1, Takahiro Masuoka1, WooChan Kim1, Ryosuke Arakawa1, Yoshiro Okubo1.   

Abstract

AIM: Dysfunction of dopaminergic neurons in the central nervous system is considered to be related to major depressive disorder (MDD). Especially, MDD in geriatric patients is characterized by anhedonia, which is assumed to be associated with reduced dopamine neurotransmission in the reward system. Dopamine transporter (DAT) is considered to reflect the function of the dopamine nerve system. However, previous DAT imaging studies using single photon emission computed tomography or positron emission tomography (PET) have shown inconsistent results. The radioligand [18 F]FE-PE2I for PET enables more precise evaluation of DAT availability. Hence, we aimed to evaluate the DAT availability in geriatric patients with MDD using [18 F]FE-PE2I.
METHODS: Eleven geriatric patients with severe MDD and 27 healthy controls underwent PET with [18 F]FE-PE2I, which has high affinity and selectivity for DAT. Binding potentials (BPND ) in the striatum (caudate and putamen), nucleus accumbens (NAc), and substantia nigra were calculated. BPND values were compared between MDD patients and healthy controls.
RESULTS: MDD patients showed significantly lower DAT BPND in the NAc (P = 0.009), and there was a trend of lower BPND in the putamen (P = 0.032) compared to controls.
CONCLUSION: We found low DAT in the NAc and putamen in geriatric patients with severe MDD, which could be related to dysregulation of the reward system.
© 2020 The Authors Psychiatry and Clinical Neurosciences © 2020 Japanese Society of Psychiatry and Neurology.

Entities:  

Keywords:  dopamine transporter; geriatric psychiatry; major depressive disorder; nucleus accumbens; positron emission tomography

Mesh:

Substances:

Year:  2020        PMID: 32363761     DOI: 10.1111/pcn.13020

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  5 in total

Review 1.  Future Prospects of Positron Emission Tomography-Magnetic Resonance Imaging Hybrid Systems and Applications in Psychiatric Disorders.

Authors:  Young-Don Son; Young-Bo Kim; Jong-Hoon Kim; Jeong-Hee Kim; Dae-Hyuk Kwon; Haigun Lee; Zang-Hee Cho
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-08

2.  Integrated Network Pharmacology and GC-MS-Based Metabolomics to Investigate the Effect of Xiang-Su Volatile Oil Against Menopausal Depression.

Authors:  Yao Li; Xinyi Yang; Shanshan Chen; Lei Wu; Jinyong Zhou; Keke Jia; Wenzheng Ju
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810

Review 3.  Influences of dopaminergic system dysfunction on late-life depression.

Authors:  Warren D Taylor; David H Zald; Jennifer C Felger; Seth Christman; Daniel O Claassen; Guillermo Horga; Jeffrey M Miller; Katherine Gifford; Baxter Rogers; Sarah M Szymkowicz; Bret R Rutherford
Journal:  Mol Psychiatry       Date:  2021-08-17       Impact factor: 15.992

4.  Dopamine dysfunction in depression: application of texture analysis to dopamine transporter single-photon emission computed tomography imaging.

Authors:  Takehiro Tamura; Genichi Sugihara; Kyoji Okita; Yohei Mukai; Hiroshi Matsuda; Hiroki Shiwaku; Shunsuke Takagi; Hiromitsu Daisaki; Ukihide Tateishi; Hidehiko Takahashi
Journal:  Transl Psychiatry       Date:  2022-08-03       Impact factor: 7.989

5.  Fully Automated GMP-Compliant Synthesis of [18F]FE-PE2I.

Authors:  Klas Bratteby; Charlotte Lund Denholt; Szabolcs Lehel; Ida Nymann Petersen; Jacob Madsen; Maria Erlandsson; Tomas Ohlsson; Matthias Manfred Herth; Nic Gillings
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.